中国铀业（001280）：IPO专题：新股精要：国内天然铀产业龙头中国铀业

Investment Rating - The investment rating for China Uranium Industry is "Buy" based on its strong market position and growth potential in the domestic natural uranium sector [1][5][28]. Core Insights - China Uranium Industry (001280.SZ) is the only company engaged in domestic natural uranium mining and processing, holding a dominant position in the industry. The company is expected to achieve revenue and net profit of 17.279 billion and 1.458 billion RMB respectively in 2024 [1][5]. - The company benefits from a large nuclear power market and has significant growth potential, supported by favorable government policies promoting nuclear energy development [6][20]. - The company has a stable revenue growth rate of 28.07% from 2022 to 2024, driven by consistent demand from downstream nuclear power plants [7][10]. Summary by Sections Company Overview - China Uranium Industry is a key player in ensuring the supply of natural uranium in China, with 17 mining rights in regions rich in uranium resources. The company ranks among the top ten uranium producers globally, with its Rosin uranium mine being the second-largest open-pit uranium mine in the world [5][24][25]. Business Analysis - The company primarily engages in the mining, sales, and trade of natural uranium and related radioactive minerals. Its revenue from natural uranium sales is projected to grow significantly, with a compound annual growth rate of 28.07% from 2022 to 2024 [7][10][12]. - The company has established long-term agreements with major nuclear power clients, ensuring stable demand for its products [6][10]. Industry Development and Competitive Landscape - The global natural uranium market is expected to expand steadily, driven by the transition to clean energy and increased nuclear power construction. The company is well-positioned to benefit from this growth [20][22]. - The competitive landscape is characterized by a high concentration of production among the top ten uranium producers, with China Uranium Industry being one of the three main suppliers in the domestic market [22][24]. IPO and Fundraising - The company plans to issue 24.818 million shares, raising approximately 4.11 billion RMB to expand its uranium production capacity and improve processing technologies [26][27]. - The IPO will enhance the company's ability to secure domestic uranium supply and support its growth strategy [26][27]. Comparable Company Valuation - The average price-to-earnings (PE) ratio for comparable companies in the industry is 26.21 for 2024, with projected ratios of 18.96 and 15.75 for 2025 and 2026 respectively [28][29].